New therapy to revert dysfunctional antibody responses during HIV-1 infection

Journal of Clinical Investigation

Volumn 120, Issue 11, 2010, Pages 3810-3813

  Chiodi, Francesca ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PROGRAMMED DEATH 1 RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBODY SPECIFICITY; ANTIBODY TITER; APOPTOSIS; CELL DIFFERENTIATION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMORAL IMMUNITY; LYMPHOID TISSUE; MEMORY CELL; NONHUMAN; NOTE; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; UPREGULATION;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; ANTIGENS, CD; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL SURVIVAL; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOID TISSUE; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 78049446938     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI44872     Document Type: Note

References (17)

1. INSIGHT-ESPRIT Study Group, et al. Interleukin-2 therapy in patients with HIV infection. N Engl J Med. 2009;361(16):1548-1559.
2. De Milito A, et al. Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection. Blood. 2004; 103(6):2180-2186. (Pubitemid 38326236)
3. Titanji K, et al. Acute depletion of activated memory B cells involves the PD-1 pathway in rapidly progressing SIV-infected macaques. J Clin Invest. 2010; 120(11):3878-3890.
4. Moir S, Fauci AS. B cells in HIV infection and disease. Nat Rev Immunol. 2009;9(4):235-245.
5. Cagigi A, Nilsson A, Pensieroso S, Chiodi F. Dysfunctional B-cell responses during HIV-1 infection: implication for influenza vaccination and highly active antiretroviral therapy. Lancet Infect Dis. 2010;10(7):499-503.
6. Titanji K, et al. Primary HIV-1 infection sets the stage for important B lymphocyte dysfunctions. AIDS. 2005;19(17):1947-1955. (Pubitemid 41669018)
7. Titanji K, et al. Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection. Blood. 2006;108(5):1580-1587. (Pubitemid 44316125)
8. Pensieroso S, et al. Timing of HAART defines the integrity of memory B cells and the longevity of humoral responses in HIV-1 vertically-infected children. Proc Natl Acad Sci U S A. 2009; 106(19):7939-7944.
9. Peruchon S, et al. Tissue-specific B-cell dysfunction and generalized memory B-cell loss during acute SIV infection. PLoS One. 2009;4(6):e5966.
10. Cagigi A, et al. Altered expression of the receptor- ligand pair CXCR5/CXCL13 in B cells during chronic HIV-1 infection. Blood. 2008; 112(12):4401-4410.
11. Okazaki T, Honjo T. The PD-1-PD-L pathway in immunological tolerance. Trends Immunol. 2006; 27(4):195-201.
12. Okazaki T, Maeda A, Nishimura H, Kurosaki T, Honjo T. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc Natl Acad Sci U S A. 2001;98(24):13866-13871. (Pubitemid 33115990)
13. Okazaki T, et al. Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nat Med. 2003;9(12):1477-1483. (Pubitemid 38004774)
14. Good-Jacobson KL, Szumilas CG, Chen L, Sharpe AH, Tomayko MM, Shlomchik MJ. PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells. Nat Immunol. 2010;11(6):535-542.
15. Nutt SL, Tarlinton DM. Give and take in the germinal center. Nat Immunol. 2010;11(6):464-466.
16. Trabattoni D, et al. B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression. Blood. 2003;101(7):2514-2520.
17. Velu V, et al. Enhancing SIV-specific immunity in vivo by PD-1 blockade. Nature. 2009; 458(7235):206-210.